Veterans Increasingly Seek Alternative Therapies to Manage PTSD, Depression and Other Challenges of Civilian Life
November 10, 2022 14:06 ET
|
Cannabis Creative Movement
DENVER, Nov. 10, 2022 (GLOBE NEWSWIRE) -- U.S. Veterans are increasingly investigating complementary or alternative treatment options like yoga, exercise, acupuncture, meditation and cannabis to...
The Headstrong Project, Inc., Receives Second Investment from The A. James & Alice B. Clark Foundation
November 10, 2022 08:00 ET
|
The Headstrong Project
New York, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The Headstrong Project Inc., a national-facing mental health treatment practice of choice providing military connected individuals and their families with...
Le lieutenant-général (ret) J.O. Michel Maisonneuve dirigera la campagne de financement à l’appui de la recherche et des traitements pour les vétérans vivant avec la douleur chronique
November 10, 2022 07:00 ET
|
Centre d’excellence sur la douleur chronique pour les vétérans canadiens
HAMILTON, Ontario, 10 nov. 2022 (GLOBE NEWSWIRE) -- Le Centre d’excellence sur la douleur chronique pour les vétérans canadiens (CESLDC) est heureux d’annoncer la nomination du lieutenant-général...
Lieutenant-General (retired) J.O. Michel Maisonneuve to lead fundraising efforts supporting research and treatment for Veterans experiencing chronic pain
November 10, 2022 07:00 ET
|
Chronic Pain Centre of Excellence for Canadian Veterans
HAMILTON, Ontario, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The Chronic Pain Centre of Excellence for Canadian Veterans (CPCoE) is excited to announce it has appointed Lieutenant-General (retired) J.O....
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
November 03, 2022 08:30 ET
|
Odyssey Health, Inc
Las Vegas, Nevada, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), a medical technology company focused on...
Post-traumatic Stress Disorder Clinical Trials Pipeline Analysis: 25+ Companies are Working to Improve the Treatment Space | DelveInsight
November 02, 2022 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Post-traumatic Stress Disorder Clinical Trials Pipeline Analysis: 25+ Companies are Working to Improve the Treatment Space | DelveInsight ...
Bionomics Limited to Participate in Upcoming November Investor Conferences
November 02, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
Quarterly Activities Report for September 2022
October 25, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, Nasdaq: BNOX), (Bionomics or the Company) a clinical-stage biopharmaceutical company developing novel, allosteric...
Bionomics Receives R&D Tax Incentive Refund for FY2022 of A$4.6 million
October 18, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical stage biopharmaceutical company, is pleased to announce that the...
Odyssey Health, Inc. Provides Recap on Concussion Drug Development
October 06, 2022 08:30 ET
|
Odyssey Health, Inc
Las Vegas, Nevada, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical...